Allograft Vasculopathy
National Taiwan University publishes research in allograft vasculopathy
Published in Cardiovascular Week, December 8th, 2008
"From July 1987 to July 2007, we performed 323 HTs with 5-year actuarial freedom from CAV of 69%, similar to the data reported by the International Society for Heart and Lung Transplantation, namely, 68% at 5 years. Therefore, CAV is not uncommon in Asia. The pathogenesis of CAV is initial endothelial injury followed by intimal hyperplasia and proliferation of vascular smooth muscle...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2008-12-08)
More Articles from Cardiovascular Week
- JAMA and Archives Journals
Gene variation for persons with diabetes associated with increased risk of coronary artery disease - JAMA and Archives Journals
Link between depression, higher risk of cardio events may be because of change in health behaviors - JAMA and Archives Journals
Receipt of heart assist pumps by Medicare patients associated with poor outcomes, high costs - Joslin Diabetes Center
Joslin research links genetic variant, poor glycemic control to coronary artery disease - Ohio University
Study shows direct link between leptin and obesity-related cardiovascular disease - Abdominal Aortic Aneurysm
Data on abdominal aortic aneurysm detailed by K.W. Cheng and co-authors - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
